Capitalism is groovy, but at what cost?

Due to the COVID-19 pandemic, the FDA was forced to bypass normal protocol and issue Emergency Use Authorization for diagnostic testing. As a result, we have seen an explosion in the number of available molecular diagnostic tests developed by various private enterprises. Our case reports of an 85-ye...

Full description

Bibliographic Details
Main Authors: Krishna Vedala, Phillip T Sobash, Shiyu Wang, Gilbert-Roy Kamoga
Format: Article
Language:English
Published: Greater Baltimore Medical Center 2020-11-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
Online Access:http://dx.doi.org/10.1080/20009666.2020.1803606